Reflecting on Several Years of Writing About Parkinson’s Disease

I published my first column with Parkinson’s News Today in April 2019, confiding in readers about my dad’s struggle with Parkinson’s disease. Since then, I’ve written more than 60 columns, telling stories and sharing information I’ve learned. I’m rather proud[…]

Depression, Anxiety Meds Tied to Disease Risk in Older Women

The use of antidepressants or anti-anxiety medications was linked to the development of Parkinson’s disease in women 65 and older, a U.S. study found. Using more than one of these medications, or changing medications over time also were significantly tied[…]

Strength Training Fails to Improve Orthostatic Hypotension in Pilot Study

Eight weeks of leg strength training failed to prevent sudden drops in blood pressure upon standing, a condition called orthostatic hypotension, in people with Parkinson’s disease, according to a small pilot study. “Further controlled clinical trials with larger sample sizes[…]

Predicting the Progression of Parkinson’s Disease

What factors can predict Parkinson’s disease progression? People with Parkinson’s disease (PD) reasonably want to know how their disease will progress over time. Unfortunately, it is very hard to predict how any individual person’s PD will evolve, and neurologists often[…]

The influence of diabetes on Parkinson’s progression

In recent research funded by Cure Parkinson's, scientists have provided the strongest evidence to date that diabetes can affect the progression of Parkinson's. The post The influence of diabetes on Parkinson’s progression appeared first on Cure Parkinson's.

Parkinson’s Disease & the Gut

Dr. Gilbert Answers Questions About Parkinson’s Disease and Gastrointestinal Issues On a recent episode of APDA’s Dr. Gilbert Hosts, I spoke with Dr. Ali Keshavarzian, a gastroenterologist with expertise on Parkinson’s disease and the gut. We covered a lot of[…]

Dr Simon Stott appointed Director of Research

Cure Parkinson’s is pleased to announce that Dr Simon Stott has been promoted to the role of Director of Research. The post Dr Simon Stott appointed Director of Research appeared first on Cure Parkinson's.

APDA-Funded Parkinson’s Research Successes: 2022 Update

APDA-funded Parkinson’s Research Successes: 2022 Update Since 1961, APDA has been a funding partner in many major scientific breakthroughs and has awarded nearly $55 million in Parkinson’s disease (PD) research grants to date. APDA funds individual research grants and fellowships[…]

The Future of Parkinson’s Disease Treatments – What’s New?

New Parkinson’s Disease Treatments in the Pipeline The pipeline for new Parkinson’s disease (PD) medications is very crowded, with multiple new medications in various stages of research development that are targeting neuroprotection, as well as motor and non-motor symptoms. In[…]

Stress, Situations, Symptoms and Parkinson's Disease

It is in the nature of chronic diseases that symptoms manifest most when our survival instincts (fight, flight, freeze) take over our body's function. This is why the severity and range of symptoms can vary moment to moment, hour to[…]

Mild Parkinsonian Signs in a Community Population

NEW Research - Is Parkinson's Genetic?? - Penetrance of Parkinson's Disease in LRRK2 Carriers Is Modified by a Polygenic Risk Score.

Salbutamol and PD risk

Improving the SoPD blog 2017 – any thoughts/suggestions?

Every six months or so, I put up a post asking for feedback/thoughts/suggestions on the style/content of the site. Or requests for any special topics readers would like to read. In this post, I also try to provide some insight[…]

A drug from Kalamazoo

Last week a research report was published in the prestigious journal Science Translational Medicine (that means that it’s potentially really important stuff). The study involved a new drug that is being clinically tested for diabetes. In last week’s study, however, the new[…]